US Cytomegalovirus Treatment Market: Innovative CMV Therapies Take Center Stage
The US cytomegalovirus treatment market is supported by increasing attention to CMV infections among immunocompromised patients, organ and stem-cell transplant recipients, and other high-risk populations. Advances in antiviral therapies and growing investment in novel treatment approaches are broadening options for CMV management. Strong clinical research capabilities, specialized healthcare...
0 Comments 0 Shares 103 Views 0 Reviews